PBTZ169

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2016
01220142016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Nitrobenzothiazinones are among the most potent antituberculosis agents. Herein, we disclose an unprecedented in vivo reduction… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2017
2017
A series of new 8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one(BTZ) derivatives containing a C-2 nitrogen spiro-heterocycle… (More)
  • figure 1
  • table 2
  • table 1
  • table 3
  • table 4
Is this relevant?
2016
2016
Electron deficient nitroaromatic compounds such as BTZ043 and its closest congener, PBTZ169, and related agents are a promising… (More)
Is this relevant?
2016
2016
Benzothiazinones (BTZs) are a class of compounds found to be extremely potent against both drug-susceptible and drug-resistant… (More)
Is this relevant?
2015
2015
Clofazimine (CZM) is an antileprosy drug that was recently repurposed for treatment of multidrug-resistant tuberculosis. In… (More)
Is this relevant?
2015
2015
BACKGROUND Mycetoma is a neglected, chronic, and deforming infectious disease caused by fungi and actinomycetes. In Mexico, N… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
8-Nitro-benzothiazinones (BTZs), such as BTZ043 and PBTZ169, inhibit decaprenylphosphoryl-β-d-ribose 2'-oxidase (DprE1) and… (More)
  • table 1
  • table 3
  • table 4
Is this relevant?
2015
2015
Tuberculosis (TB) remains a major human health problem. New therapeutic antitubercular agents are urgent needed to control the… (More)
Is this relevant?
2014
2014
The benzothiazinone lead compound, BTZ043, kills Mycobacterium tuberculosis by inhibiting the essential flavo-enzyme DprE1… (More)
Is this relevant?